Crossmark

Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study

Crossref DOI link: https://doi.org/10.1186/s13014-018-0976-3

Published Online: 2018-02-23

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Straube, Christoph http://orcid.org/0000-0002-7175-0859
Oechsner, Markus

Kampfer, Severin

Scharl, Sophia

Schmidt-Graf, Friederike

Wilkens, Jan J.

Combs, Stephanie E.
More Information

Article History

Received: 19 November 2017

Accepted: 15 February 2018

First Online: 23 February 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: CS: received a Scholarship from Medac GmbH, received travel Grant from NovoCure; MO, SK, SS, JW: No conflict of interest.FSG: served as author for Medac GmbH; SEC: Advisory board of Bristol-Myers-Squibb, Advisor for BrainLab, Author for Medac GmbH.The remaining authors declare to have no conflict of interest do declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.